Coherus Oncology (CHRS) Gross Margin Growth (3y) (2022 - 2026)
Coherus Oncology (CHRS) Gross Margin Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14,836.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 589.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 53.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,244.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 569.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Coherus Oncology | 221.39 Mn | 116.08 Mn | 10.07 Mn | 1,267.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,267.00 |
| Mar 31, 2026 | 2,104.00 |
| Dec 31, 2025 | -42.00 |
| Sep 30, 2025 | 4,541.00 |
| Jun 30, 2025 | -1,436.00 |
| Mar 31, 2025 | -1,933.00 |
| Dec 31, 2024 | -1,906.00 |
| Sep 30, 2024 | -1,930.00 |
| Jun 30, 2024 | 148.00 |
| Mar 31, 2024 | -5,330.00 |
| Dec 31, 2023 | -8,183.00 |
| Sep 30, 2023 | -3,593.00 |
| Jun 30, 2023 | -3,485.00 |
| Mar 31, 2023 | -4,612.00 |
| Dec 31, 2022 | -2,501.00 |
| Sep 30, 2022 | -7,179.00 |
| Jun 30, 2022 | -1,803.00 |
| Mar 31, 2022 | -959.00 |